Trial Profile
A phase III, randomized, double-blind, placebo-controlled study to confirm the effectiveness and safety of ALGRX 3268 [lidocaine] in pediatric subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Procedural pain
- Focus Registrational; Therapeutic Use
- Acronyms COMFORT-003
- 01 May 2008 Results have been published.
- 11 Nov 2005 New trial record.